Neo-adjuvant chemotherapy and axillary de-escalation management for patients with clinically node-negative breast cancer
{{output}}
This study aimed to explore the optimal time of sentinel lymph node biopsy (SLNB) and neo-adjuvant chemotherapy (NAC) and to assess the feasibility of selective elimination of axillary surgery after NAC in clinically node-negative (cN0) patients. From April 20... ...
